Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer- A quality improvement project.
Journal: Gynecologic oncology
Published: April 02, 2026
Socioeconomic marginalization is associated with delayed medical consultation among endometrial cancer patients presenting with postmenopausal bleeding.
Journal: Menopause (New York, N.Y.)
Published: February 25, 2025
Outcomes of low-risk endometrial cancer with isolated tumor cells in the sentinel lymph nodes: a prospective, multi-center, single-arm, observational study (ENDO-ITC study).
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: December 06, 2024
Sentinel lymph node sampling versus full lymphadenectomy in endometrial cancer: a SEER database analysis.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 24, 2023
Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233].
Journal: Cancer letters
Published: April 27, 2023
Bilateral or unilateral tubo-ovarian abscess: exploring its clinical significance.
Journal: BMC women's health
Published: January 02, 2023
Upfront surgery in patients with epithelial ovarian cancer and enlarged supradiaphragmatic lymph nodes associated with comparable to neoadjuvant chemotherapy.
Journal: BMC women's health
Published: October 01, 2022
Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriers.
Journal: International journal of cancer
Published: March 15, 2022
Predictors of uncommon location of sentinel nodes in endometrial and cervical cancers.
Journal: Gynecologic oncology reports
Published: October 30, 2021
High grade, advanced, serous ovarian cancer with low serum CA125 levels.
Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
Published: January 11, 2021
DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer.
Journal: Cancer letters
Published: August 13, 2020
Age is an independent predictor of outcome in endometrial cancer patients: An Israeli Gynecology Oncology Group cohort study.
Journal: Acta obstetricia et gynecologica Scandinavica
Published: June 06, 2020
Last Updated: 09/26/2026